Literature DB >> 33367581

Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons.

Xiuwen Wu1, Jie Wu1,2, Peige Wang3, Xueling Fang4, Yunsong Yu5, Jianguo Tang6, Yonghong Xiao7, Minggui Wang8, Shikuan Li3, Yun Zhang9, Bijie Hu10, Tao Ma11, Qiang Li12, Zhiming Wang13, Anhua Wu14, Chang Liu15, Menghua Dai16, Xiaochun Ma17, Huimin Yi18, Yan Kang19, Daorong Wang20, Gang Han21, Ping Zhang22, Jianzhong Wang23, Yufeng Yuan24, Dong Wang25, Jian Wang26, Zheng Zhou27, Zeqiang Ren28, Yuxiu Liu1, Xiangdong Guan29, Jianan Ren1.   

Abstract

The Chinese guidelines for IAI presented here were developed by a panel that included experts from the fields of surgery, critical care, microbiology, infection control, pharmacology, and evidence-based medicine. All questions were structured in population, intervention, comparison, and outcomes format, and evidence profiles were generated. Recommendations were generated following the principles of the Grading of Recommendations Assessment, Development, and Evaluation system or Best Practice Statement (BPS), when applicable. The final guidelines include 45 graded recommendations and 17 BPSs, including the classification of disease severity, diagnosis, source control, antimicrobial therapy, microbiologic evaluation, nutritional therapy, other supportive therapies, diagnosis and management of specific IAIs, and recognition and management of source control failure. Recommendations on fluid resuscitation and organ support therapy could not be formulated and thus were not included. Accordingly, additional high-quality clinical studies should be performed in the future to address the clinicians' concerns.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antimicrobial therapy; intraabdominal infection; nutrition; source control; treatment failure

Year:  2020        PMID: 33367581     DOI: 10.1093/cid/ciaa1513

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  Safety and Reverence: How Roman Catholic Liturgy Can Respond to the COVID-19 Pandemic.

Authors:  Sergey Budaev
Journal:  J Relig Health       Date:  2021-05-24

2.  Antibodies to SARS-CoV-2 and risk of past or future sick leave.

Authors:  Joakim Dillner; K Miriam Elfström; Jonas Blomqvist; Carina Eklund; Camilla Lagheden; Sara Nordqvist-Kleppe; Cecilia Hellström; Jennie Olofsson; Eni Andersson; August Jernbom Falk; Sofia Bergström; Emilie Hultin; Elisa Pin; Anna Månberg; Peter Nilsson; My Hedhammar; Sophia Hober; Johan Mattsson; Laila Sara Arroyo Mühr; Kalle Conneryd Lundgren
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  Recurrent COVID-19 infection in a health care worker: a case report.

Authors:  Jaya Garg; Jyotsna Agarwal; Anupam Das; Manodeep Sen
Journal:  J Med Case Rep       Date:  2021-07-12

Review 4.  Asymptomatic carriage and transmission of SARS-CoV-2: What do we know?

Authors:  Susan Lee; Paula Meyler; Michelle Mozel; Tonia Tauh; Richard Merchant
Journal:  Can J Anaesth       Date:  2020-06-02       Impact factor: 6.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.